ロード中...
Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study
BACKGROUND: Hepatocellular carcinoma (HCC) is a common malignant tumor with characteristics of poor prognosis, high morbidity and mortality worldwide. In particular, only a few systemic treatment options are available for advanced HCC patients, and include sorafenib and the recently described atezol...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7526186/ https://ncbi.nlm.nih.gov/pubmed/32993568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07447-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|